Ignite Creation Date:
2025-12-25 @ 4:30 AM
Ignite Modification Date:
2026-02-22 @ 6:46 PM
Study NCT ID:
NCT03791918
Status:
WITHDRAWN
Last Update Posted:
2019-05-02
First Post:
2019-01-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria
Sponsor:
Sun Yat-sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-01-01
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-01-01
First Submit QC Date:
None
Study First Post Date:
2019-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-30
Last Update Post Date:
2019-05-02
Last Update Post Date Type:
ACTUAL